Pregnancy with portal hypertension.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 4116711)

Published in J Clin Exp Hepatol on June 23, 2014

Authors

Neelam Aggarwal1, Neha Negi1, Aakash Aggarwal2, Vijay Bodh3, Radha K Dhiman3

Author Affiliations

1: Department of Obstetrics & Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
2: Department Of Internal Medicine, State University of New York (Suny) Upstate Syracuse, NY, USA.
3: Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

Articles cited by this

Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (2007) 9.44

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78

Primary biliary cirrhosis. Hepatology (2009) 5.35

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (1988) 4.32

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology (2010) 2.68

Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60

Splanchnic artery aneurysms. Mayo Clin Proc (2007) 2.55

ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc (2005) 1.99

The management of splenic artery aneurysms: experience with 23 cases. Am J Surg (1995) 1.97

Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol (1985) 1.93

Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol (2010) 1.66

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology (2002) 1.57

Consensus on extra-hepatic portal vein obstruction. Liver Int (2006) 1.47

Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation (2006) 1.37

The AAPM/RSNA physics tutorial for residents. Typical patient radiation doses in diagnostic radiology. Radiographics (1999) 1.36

Pregnancy outcome in liver transplant recipients. Obstet Gynecol (2003) 1.23

Rupture of splenic artery aneurysm in a pregnant patient with portal hypertension. Am J Obstet Gynecol (1996) 1.19

Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis (1986) 1.12

Pregnancy in patients with hepatic cirrhosis. Management and outcome. Lancet (1968) 1.10

Extra hepatic portal vein obstruction and pregnancy outcome: largest reported experience. J Obstet Gynaecol Res (2011) 1.03

Endoscopy in pregnancy. Best Pract Res Clin Gastroenterol (2007) 1.02

Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract (2003) 1.01

Cirrhosis and portal hypertension in pregnancy. Semin Perinatol (1998) 1.01

Pregnancy and cirrhosis. Liver Transpl (2008) 1.01

Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome. J Hepatol (2012) 1.00

Non-cirrhotic portal hypertension in pregnancy. Int J Gynaecol Obstet (2001) 0.98

Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol (2004) 0.98

Pregnancy and liver transplantation. Obstet Gynecol (1990) 0.98

Pregnancy and cirrhosis of the liver. Aust N Z J Obstet Gynaecol (1999) 0.94

Pregnancy outcomes among liver transplant recipients in the United States: a nationwide case-control analysis. Liver Transpl (2010) 0.93

Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl (2005) 0.91

Non-cirrhotic portal hypertension and pregnancy outcome. J Obstet Gynaecol Res (2008) 0.90

Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol (2009) 0.89

Pregnancy in liver cirrhosis. Assessment of maternal and fetal risks in eleven patients and review of the management. Gynecol Obstet Invest (1994) 0.88

Pregnancy and portal hypertension a pathology view of physiologic changes. Ann Hepatol (2006) 0.88

Pregnancy and esophageal varices. Am J Surg (1982) 0.88

Pregnancy in liver cirrhosis and/or portal hypertension. Am J Obstet Gynecol (1977) 0.87

Elective forceps delivery and extradural anaesthesia in a primigravida with portal hypertension and oesophageal varices. Br J Anaesth (1996) 0.86

Is pregnancy safe with extrahepatic portal vein obstruction? An analysis. Singapore Med J (2012) 0.85

The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int (2009) 0.85

Liver transplantation during pregnancy. Transplant Proc (1993) 0.85

Ischemic injury to the fetus after maternal liver transplantation. J Ultrasound Med (1994) 0.85

Intrapartum orthotopic liver transplantation with successful outcome of pregnancy. Transplantation (1990) 0.85

Portal vein thrombosis associated with pregnancy. A case report. J Reprod Med (1993) 0.84

Pregnancy and liver disease. Gastroenterol Clin North Am (2003) 0.84

Liver cirrhosis and pregnancy. Ann Hepatol (2006) 0.84

Prophylactic banding of severe esophageal varices associated with liver cirrhosis in pregnancy. Obstet Gynecol (1999) 0.83

Pregnancy and its outcome in patients with noncirrhotic portal hypertension. Dig Dis Sci (1999) 0.82

Impact of cirrhosis and liver transplant on maternal health during labor and delivery. Clin Gastroenterol Hepatol (2009) 0.81

Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature. BJOG (2001) 0.81

Pregnancy and delivery in patients with portal vein cavernoma. Gynecol Obstet Invest (2009) 0.81

Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol (2011) 0.80

Pregnancy outcome in Budd Chiari Syndrome--a tertiary care centre experience. Arch Gynecol Obstet (2013) 0.80

Liver disease in pregnancy. Am J Gastroenterol (2004) 0.80

Endoscopic injection sclerotherapy for esophageal varices during pregnancy. J Clin Gastroenterol (1994) 0.79

Endoscopic band ligation: a safe technique to control bleeding esophageal varices in pregnancy. Gastrointest Endosc (1998) 0.78

Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman. Dig Liver Dis (2007) 0.78

Exacerbation of liver cirrhosis in pregnancy: a complex emerging clinical situation. Arch Gynecol Obstet (2008) 0.78

Endoscopic sclerotherapy during pregnancy. Am J Gastroenterol (1990) 0.78

Management of variceal bleeding in pregnancy with endoscopic variceal ligation and N-butyl-2-cyanoacrylate: report of three cases. Gastrointest Endosc (2000) 0.78

Pregnancy in cirrhotic and noncirrhotic portal hypertension. Obstet Gynecol (1977) 0.78

Transjugular intrahepatic portosystemic shunt creation for recurrent gastrointestinal bleeding during pregnancy. J Vasc Interv Radiol (2007) 0.77

[New TIPS placement in pregnancy in recurrent esophageal varices hemorrhage--assessment of fetal radiation exposure]. Rofo (1998) 0.77

ACOG committee opinion. Breastfeeding and the risk of hepatitis C virus transmission. Number 220, August 1999. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet (1999) 0.77

Endoscopic sclerotherapy in extrahepatic portal hypertension in pregnancy. Am J Obstet Gynecol (1991) 0.76

[Cardiovascular changes during pregnancy]. Herz (2003) 0.76

Cirrhosis--pregnancy and delivery: a review. Obstet Gynecol Surv (1982) 0.76

Articles by these authors

Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol (2014) 1.08

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol (2016) 1.02

Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy. J Clin Exp Hepatol (2013) 1.00

Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol (2014) 0.96

A guide to the management of tuberculosis in patients with chronic liver disease. J Clin Exp Hepatol (2012) 0.85

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015. J Clin Exp Hepatol (2015) 0.85

Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol (2014) 0.83

Gut microbiota, inflammation and hepatic encephalopathy: a puzzle with a solution in sight. J Clin Exp Hepatol (2012) 0.77

Tackling the Hepatitis C Disease Burden in Punjab, India. J Clin Exp Hepatol (2016) 0.75

Hepatobiliary Quiz (Answers)-16 (2015). J Clin Exp Hepatol (2015) 0.75

Spontaneous rupture of hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.75

Hepatobiliary Quiz Answers - 18 (2016). J Clin Exp Hepatol (2016) 0.75

Hepatobiliary quiz-9 (2014). J Clin Exp Hepatol (2014) 0.75

Pseudoparallel channel sign on ultrasonography in alcoholic hepatitis. J Clin Exp Hepatol (2014) 0.75

Hepatobiliary quiz-3 (2012). J Clin Exp Hepatol (2012) 0.75

Hepatobiliary Quiz Answers-17 (2016). J Clin Exp Hepatol (2016) 0.75

Hepatobiliary quiz-7 (2013). J Clin Exp Hepatol (2013) 0.75

Liver-bud Transplantation: A Bud That May Bloom into the Future of Regenerative Medicine. J Clin Exp Hepatol (2013) 0.75

Hepatobiliary quiz 11 (2014). J Clin Exp Hepatol (2014) 0.75

Hepatobiliary quiz-6 (2013). J Clin Exp Hepatol (2013) 0.75

Biomimetic enzyme nanocomplexes: use as antidotes and preventive measures for alcohol intoxication. J Clin Exp Hepatol (2013) 0.75

Hepatobiliary quiz-10 (2014). J Clin Exp Hepatol (2014) 0.75

Can Testing the Impact of Minimal Hepatic Encephalopathy on Driving Skills be Prolific to Translate Research to Real Life Clinical Medicine? J Clin Exp Hepatol (2016) 0.75

Hepatobiliary quiz-12 (2014). J Clin Exp Hepatol (2014) 0.75

Hepatobiliary Quiz Answers-19 (2016). J Clin Exp Hepatol (2016) 0.75

Hepatobiliary Quiz (Answers)-15 (2015). J Clin Exp Hepatol (2015) 0.75

Hepatobiliary quiz-5 (2013). J Clin Exp Hepatol (2013) 0.75

Hepatobiliary quiz-8 (2013). J Clin Exp Hepatol (2013) 0.75

Hepatobiliary quiz (answers)-13 (2015). J Clin Exp Hepatol (2015) 0.75

Answers to multiple choice questions. J Clin Exp Hepatol (2012) 0.75

Hepatobiliary Quiz (Answers)-14 (2015). J Clin Exp Hepatol (2015) 0.75

Hepatobiliary quiz-6 (2013). J Clin Exp Hepatol (2013) 0.75

Hepatobiliary quiz-9 (2014). J Clin Exp Hepatol (2014) 0.75

Multiple choice questions. J Clin Exp Hepatol (2012) 0.75

The third year: thrice as good! J Clin Exp Hepatol (2013) 0.75

Patient with liver cirrhosis and hemorrhagic ascites. J Clin Exp Hepatol (2014) 0.75

The Fifth Year of JCEH: The Year of Recognition. J Clin Exp Hepatol (2015) 0.75

Hepatobiliary quiz-5 (2013). J Clin Exp Hepatol (2013) 0.75

Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs? J Clin Exp Hepatol (2017) 0.75

Hepatobiliary quiz-3 (2012). J Clin Exp Hepatol (2012) 0.75

Hepatobiliary quiz-7 (2013). J Clin Exp Hepatol (2013) 0.75

Hepatobiliary quiz-8 (2013). J Clin Exp Hepatol (2013) 0.75

Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]. J Clin Exp Hepatol (2016) 0.75

Hepatobiliary quiz-10 (2014). J Clin Exp Hepatol (2014) 0.75

Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol (2017) 0.75